Modern Vaccine Development
Creation of vaccines (e.g., mRNA, viral vector) using advanced molecular biology and genetic engineering for rapid development and high efficacy.
Core metadata
- ID: vaccine_development_modern
- Era: Modern
- First known date: 1973 (decade)
- Region: Global vaccine research and manufacturing
- Review status: source_checked
- Maturity: established
Prerequisites
- Advanced Immunology (immunology_advanced)
- Mass Production (mass_production)
- Recombinant DNA & Genetic Engineering (recombinant_dna_genetic_engineering)
Dependents
Fields
Field lanes
- Pharmaceuticals & Drug Development: Biologics & Vaccines
Node sources
- Vaccines (U.S. Food and Drug Administration, 2026, official_agency) • Supports: node, maturity
- How Vaccines are Developed and Approved for Use (CDC, 2026, official_agency) • Supports: node, maturity
Prerequisite edge evidence
Edge/source evidence summary:
- Prerequisite edges: 3
- Average edge confidence: 73%
- Prerequisite sources: 3
- expert_inference: 3
| Prerequisite | Type | Confidence | Evidence level | Note | Sources |
|---|---|---|---|---|---|
| Advanced Immunology (immunology_advanced) | enabling | 68% | expert_inference | Advanced Immunology provides a capability that enables this technology without being the only possible path. |
|
| Recombinant DNA & Genetic Engineering (recombinant_dna_genetic_engineering) | required | 82% | expert_inference | Recombinant DNA & Genetic Engineering is modeled as a necessary component or method for this technology in the current graph. |
|
| Mass Production (mass_production) | enabling | 68% | expert_inference | Mass Production provides a capability that enables this technology without being the only possible path. |
|
This page is generated from canonical era JSON and is indexable by URL.